The USFDA has issued a form 483 with 10 observations after inspection of Sun Pharma's Halol facility. The unit, however, now has a low contribution to the company’s turnover. The Halol facility was classified ‘Official Action Indicated (OAI)’ in March 2020, and was awaiting re-inspection from the US regulator. Due to the pandemic related travel restrictions, the re-inspection got delayed, and now the USFDA has issued a form 483 with observations. Sun Pharma said that the US Food and Drugs Administration (USFDA) did a Good Manufacturing Practices (GMP) inspection of Sun Pharmaceutical Industries Halol facility in Gujarat from April 26 to May 9, 2022. The Company is preparing the response to the observations, which will be submitted to the US FDA within 15 business days.
Consider the following Statements about Samagra Shiksha Abhiyan and choose the option with correct Statements.
(1) Samagra Shiksha Abhiyan was...
How many products are included in the Wholesale Price Index (WPI)?
India has done commendable job with respect to almost all the SDGs. What is India’s overall score in the SDG India Index 2023-24?
Consider the following Statements.
(i) International Financial Services Centres Authority is constitutional body.
<...Under the Agriculture Infrastructure Fund (AIF scheme), what is the interest subvention rate provided for loans?
Which of the following correctly describes an Open Economy?
National Dairy Research Institute is one of the premier institutes in the dairy sector, which has contributed a lot in the growth of the dairy industry ...
______________ means complete dependence on another countries rule.
The Ministry of Defence signed MoUs with which banks to onboard them as SPARSH Service Centres?
The Central Theme Report database and publication are updated and published twice a year, usually in ___________.
